IL-18: The Double-Edged Cytokine | Community Health

Interleukin-18 (IL-18) is a cytokine that plays a crucial role in the regulation of immune responses, with a vibe score of 8 due to its significant impact on various diseases. First discovered in 1989 by T. Okamura, IL-18 is produced by macrophages and other cells, and its effects are context-dependent, ranging from pro-inflammatory to anti-inflammatory. The controversy surrounding IL-18 stems from its potential to exacerbate autoimmune diseases, such as rheumatoid arthritis, while also showing promise as a therapeutic target for cancer treatment. With an influence flow that connects it to other key cytokines like IL-12 and IL-1β, IL-18's mechanisms are still being unraveled, with recent studies highlighting its role in modulating the gut-brain axis. As research continues to uncover the complexities of IL-18, its potential applications in medicine are becoming increasingly evident, with a perspective breakdown that is 40% optimistic, 30% neutral, and 30% pessimistic. The entity type is a cytokine, and it has been the subject of intense study in recent years, particularly in the context of its relationship to other immune system components.